TELFORD, PA — Dräger’s Atlan® A350 and A350XL Anesthesia Machines have been awarded the prestigious Innovative Technology Product designation by Vizient, Inc., the largest healthcare performance improvement organization in the United States. This recognition underscores the product’s ability to enhance clinical care, patient and healthcare worker safety, and operational efficiency in healthcare settings.
The Atlan A350/A350XL series, showcased at the Vizient Innovative Technology Exchange, has been lauded for its advanced features that support critical care teams while promoting environmentally sustainable practices. Equipped with a state-of-the-art electronic piston ventilator, the Atlan ensures precise ventilation for patients of all sizes, from neonates to adults. Its design is aimed at preventing clinical risks such as unintentional high tidal volumes and inspiratory pressures, bolstering patient safety during procedures.
The machines are optimized for low- and minimal-flow anesthesia, incorporating tools like the Low Flow Wizard, which improves efficiency by standardizing practices and minimizing anesthetic agent consumption. Additionally, a warmed breathing system reduces condensation under low-flow conditions, further enhancing both clinical and operational performance while reducing waste.
“Dräger is committed to shaping the future of healthcare with technology that serves both people and the planet,” said David Karchner, Senior Director of Marketing, Operating Room, Monitoring, and Government Solutions at Draeger, Inc. “The Atlan family is more than just an anesthesia workstation — it’s a statement of our commitment to critical care and sustainable healthcare practices. Our goal with the Atlan introduction was to provide our healthcare partners the tools to improve their clinical, financial, and operational efficiency, while also supporting their sustainability efforts. Receiving the Innovative Technology Designation from Vizient validates that we’re on the right track.”
This designation, awarded after review by Vizient’s member-led councils, signifies the product’s unique contributions to healthcare. “What makes a product worthy of this designation is that it has a unique quality that differentiates it from its competitors,” said Kelly Flaharty, senior director of contract services and leader of the Vizient Innovative Technology Program. “Our provider customer council determined that Dräger met this standard and recognizes its potential to improve quality outcomes.”
Dräger’s Atlan family represents a significant advancement in both clinical technology and environmental responsibility, reaffirming the company’s role as a leader in innovative solutions for critical care.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.